ロード中...
One-Year Follow-Up after Endobronchial Valve Treatment in Patients with Emphysema without Collateral Ventilation Treated in the STELVIO Trial
BACKGROUND: One-way endobronchial valve (EBV) treatment has shown safety and efficacy at 6 months after treatment in patients with severe emphysema and confirmed absence of interlobar collateral ventilation. Longer follow-up in this subgroup is not available. OBJECTIVES: To investigate the efficacy...
保存先:
| 出版年: | Respiration |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348732/ https://ncbi.nlm.nih.gov/pubmed/27974713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000453529 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|